AP NEWS

Global Antifungal Drugs Market 2018-2022 | Increase in Antifungal Research Funding to Boost Growth | Technavio

December 26, 2018

LONDON--(BUSINESS WIRE)--Dec 26, 2018-- analysts forecast the global antifungal drugs market to grow at a CAGR of over 3% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181226005051/en/

Technavio has published a new market research report on the global antifungal drugs market from 2018-2022. (Graphic: Business Wire)

The use of antifungal combination is one of the major trends being witnessed in the . Clinicians are increasingly prescribing combination therapies over monotherapies after the research revealed synergism between several antifungals. In addition, the availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations. The pharmacological benefits of combination antifungals include synergic action, with one drug acting on infection from a body system while the other agent clears it from another site.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global antifungal drugs market is the Increase in antifungal research funding:

Global antifungal drugs market: Increase in antifungal research funding

Several organizations are investing huge amounts for antifungal research. For instance, organizations such as the British Society for Antimicrobial Chemotherapy, The Wellcome Trust Strategic Award in Medical Mycology and Fungal Immunology, and the European Society of Clinical Microbiology and Infectious Diseases have been providing research funds for studies in the fungal infection therapy area. In many European countries, government funding is also available for research in fungal diseases. Such increase in antifungal research funding is expected to fuel the growth of the global antifungal drugs market during the forecast period.

According to a senior analyst at Technavio for research on infectious and rare diseases, “Apart from the increase in antifungal research funding, factors such as the emerging new targets for treatment of resistant fungal infections, and the increasing prevalence of fungal infection are expected to positively impact the growth of the global antifungal drugs market during the forecast period.”

Global antifungal drugs market: Segmentation analysis

The global antifungal drugs market research report provides market segmentation by route of administration (topical, oral, and parenteral), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2017, accounting for over 39% share, followed by EMEA and APAC respectively. Although the APAC region held the smallest share of the market in 2017, it is expected to register the highest incremental growth during the forecast period.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181226005051/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 12/26/2018 09:05 AM/DISC: 12/26/2018 09:05 AM

http://www.businesswire.com/news/home/20181226005051/en

AP RADIO
Update hourly